LB Pharmaceuticals Stock (NASDAQ:LBRX)
Previous Close
$31.41
52W Range
$13.36 - $33.47
50D Avg
$27.76
200D Avg
$21.63
Market Cap
$850.55M
Avg Vol (3M)
$248.35K
Beta
1.38
Div Yield
-
LBRX Company Profile
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.